RaNA licenses Shire's mRNA technology
Shire PLC sold RaNA Therapeutics Inc. its messenger RNA platform (MRT).
- Antisense, Oligonucleotides
- Includes Equity
- Includes Royalty or Profit Split Information
- Product Purchase
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.